Lacprodan® (Whey and Milk Protein Ingredients — Arla Foods Ingredients)

Evidence Level
Limited
4 Clinical Trials
6 Documented Benefits
2/5 Evidence Score

Lacprodan® is a range of whey and milk protein ingredients made by Arla Foods Ingredients for clinical and sports nutrition. The sports and clinical grades include Lacprodan® ALPHA-50 (an alpha-lactalbumin enriched whey), Lacprodan® DI-3092 (an extensively hydrolyzed whey) and Lacprodan® HYDRO.365 (a hydrolyzed whey for sports products). A search of PubMed finds no human trial of these three grades for muscle, recovery or performance, so the muscle and recovery sections rest on general whey and protein research. A different grade does have published adult trials: Lacprodan® PL-20, a milk protein concentrate rich in milk fat globule membrane. It has been tested in healthy adults given a weakened, diarrhoea causing strain of E. coli, and as a milk phospholipid drink in stressed men. A planned PL-20 memory trial in older adults has no published results.

Studied Dose No study has tested ALPHA-50, DI-3092 or HYDRO.365, so they have no studied dose. The cited whey studies used 20 to 45 g per serving. Lacprodan PL-20 was tested at 10 g twice daily for 4 weeks in healthy adults.
Active Compound Whey and milk protein fractions from Arla Foods Ingredients. ALPHA-50 is an alpha-lactalbumin enriched whey, DI-3092 and HYDRO.365 are whey hydrolysates, and PL-20 is a milk protein concentrate rich in milk fat globule membrane phospholipids.

Benefits

Whey protein and muscle protein synthesis

Whey protein supplies a leucine rich, quickly absorbed mix of essential amino acids that supports muscle protein synthesis. A pooled analysis of 49 resistance training trials in 1,863 adults found that adding protein gave about 2.5 kg more on a one repetition maximum strength test and 0.3 kg more fat free mass than training alone. None of those trials used a Lacprodan ingredient, so this rests on protein as a class.

Whey hydrolysate and post-exercise recovery

Fast digesting whey is used after exercise to supply amino acids to muscle, and hydrolyzed whey grades are made for recovery products. Direct tests are few and disagree: knee strength recovered faster after hard eccentric exercise in one trial, but only six men took the hydrolysate, and in trained cyclists adding whey hydrolysate to a carbohydrate drink did not change next day time trial performance. Neither used a Lacprodan ingredient.

Higher short-term insulin response with hydrolyzed whey

In 16 healthy men given 45 g of protein, peak blood insulin was about 28 percent higher after hydrolyzed whey than after whey isolate, but the difference in total insulin over time was not statistically significant. That is a blood hormone measure, not a muscle or performance result, and in trained cyclists a whey hydrolysate raised insulin without improving next day performance. No Lacprodan grade was tested.

Use in clinical nutrition products (DI-3092)

Arla describes Lacprodan® DI-3092 as a highly hydrolyzed whey (16 to 22 percent degree of hydrolysis) with a mild taste and low viscosity, designed for peptide-based medical nutrition drinks holding 10 g of protein per 100 mL. Those are formulation properties, not clinical outcomes, and no published human trial of DI-3092 was found.

Digestive comfort during a gut challenge (Lacprodan PL-20)

In a 4 week double blind trial in 58 healthy adults, 10 g of Lacprodan PL-20 twice daily was compared with sodium caseinate before a dose of a weakened, diarrhoea causing E. coli strain. Fecal output and E. coli shedding did not differ, but the PL-20 group reported fewer extra stools and fewer gut complaints. Symptoms were mild and brief, and Arla staff co-authored the study.

Milk phospholipids (PL-20) and memory under stress

In 75 chronically stressed men aged 30 to 51, a milk drink with added milk phospholipids for 42 days changed the morning cortisol pattern but not the cortisol response to a stress test. Better memory after the stress test appeared only in an exploratory analysis of older men on the higher dose. A later review identifies the ingredient as Lacprodan PL-20. A larger PL-20 memory trial in older adults has no published results.

Mechanism of action

1

Leucine-driven mTORC1 activation

Whey protein is rich in leucine, the primary essential amino acid trigger for mTORC1-driven muscle protein synthesis.

2

Rapid amino acid absorption from hydrolysates

Enzymatic hydrolysis pre-digests intact whey into di- and tri-peptides that are absorbed via peptide transporters such as PepT1, accelerating amino acid appearance compared with intact whey or casein. Faster appearance is a measurable difference rather than a demonstrated advantage: the human evidence that hydrolyzed whey outperforms intact whey for muscle growth, recovery or performance is limited and inconsistent, and none of it used a Lacprodan ingredient.

3

Insulinotropic effect supporting nutrient delivery

Hydrolyzed whey produces a higher postprandial insulin response than native whey, which is proposed to help move nutrients and amino acids into skeletal muscle. The insulin difference itself is documented; the recovery benefit downstream of it is an inference that has not been shown. One crossover trial in trained cyclists found that a whey hydrolysate raised post-exercise insulin without improving next-day performance.

Clinical trials

1
Hydrolyzed Whey vs Native Whey: Insulin Response
PubMed

Acute study comparing the insulin response to drinking native whey protein isolate or whey protein hydrolysate, with analysis of insulin-releasing amino acids. (Power et al. 2009, Amino Acids)

Sixteen healthy men, each drinking 500 mL containing 45 g of either whey protein isolate or whey protein hydrolysate on separate occasions.

Peak plasma insulin was about 28 percent higher after the hydrolysate than after whey protein isolate. The 43 percent difference in total insulin exposure over time was not statistically significant, and gastric emptying was unchanged. The study measured no muscle, recovery or performance outcome, and it used generic whey, not a Lacprodan ingredient.

2
Extracellular Amino Acid Availability and Muscle Protein Synthesis
PubMed

Dose response study of how human muscle protein synthesis responds to amino acid levels in the blood versus inside the muscle, using stable isotope tracers. (Bohé et al. 2003, J Physiol)

Twenty-one healthy adults (11 men, 10 women, average age 29) given mixed amino acids by intravenous infusion, not by mouth, with muscle protein synthesis traced using stable isotopes.

Muscle protein synthesis was modulated by extracellular (blood) amino acid availability rather than intramuscular concentrations, following a hyperbolic dose-response relationship. Because the amino acids were delivered into a vein rather than swallowed, this study bypasses digestion and absorption altogether, so it cannot show what any oral protein powder does. It also involved no whey, no hydrolysate and no Lacprodan ingredient. It is background physiology, not evidence for this product.

3
Plant vs Animal Protein Anabolic Response
PubMed

Narrative review comparing the muscle building response to plant and animal proteins, with attention to leucine content and amino acid profile. (van Vliet et al. 2015, J Nutr)

A narrative review of other researchers' studies rather than a trial. It compared plant proteins, mainly soy and wheat, with animal proteins; it did not test hydrolysis, did not test any Lacprodan ingredient, and its authors noted that few studies had actually measured the muscle protein response to plant proteins.

Plant proteins generally produce a smaller per gram muscle building response than animal proteins, partly because of lower leucine content. This is a general case for dairy protein, not evidence for any Lacprodan grade.

4
Lacprodan PL-20 and an E. coli Challenge
PubMed

Randomized, placebo controlled, double blind, 4 week parallel trial of Lacprodan PL-20, a milk protein concentrate rich in milk fat globule membrane, against sodium caseinate. Three authors worked for Arla. (Ten Bruggencate et al. 2016, J Nutr)

58 healthy adults (30 on PL-20, 28 on control) taking 10 g twice daily; after 2 weeks all drank a live, weakened, diarrhoea causing E. coli strain.

The main measures, fecal output and E. coli shedding, did not differ between groups. Reported stool frequency (1.1 vs 1.6 stools a day) and gut complaints on day 2 were lower with PL-20. Symptoms were mild and resolved within 2 days in both groups. A single trial.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated in healthy adults at typical whey protein doses.
Mild gastrointestinal discomfort, gas, or bloating possible.
Not appropriate for individuals with cow's milk protein allergy. Hydrolysis reduces but does not eliminate the allergenic fragments of milk protein, so a hydrolyzed whey is not a safe substitute for someone with a diagnosed milk allergy unless a clinician says otherwise.
Lactose content differs between grades, so people sensitive to lactose should check the product label.
High protein intakes warrant clinician input in advanced kidney disease.

Important Drug interactions

Levodopa: high protein meals can reduce levodopa absorption, so people with Parkinson's disease should follow their prescriber's advice on protein timing.
Bisphosphonates (such as alendronate): take as the drug label directs, apart from food and drinks, to avoid reduced absorption.
Antibiotics that must be taken on an empty stomach (such as tetracyclines): separate from protein drinks so absorption is not reduced.
Diabetes medicines: hydrolyzed whey can raise the insulin response after a meal, so people using insulin or other glucose lowering drugs should watch their blood sugar when adding it.

Frequently asked questions about Lacprodan® (Whey and Milk Protein Ingredients — Arla Foods Ingredients)

What is Lacprodan?

Lacprodan® is a range of whey and milk protein ingredients made by Arla Foods Ingredients for clinical and sports nutrition. The sports and clinical grades include Lacprodan® ALPHA-50 (an alpha-lactalbumin enriched whey), Lacprodan® DI-3092 (an extensively hydrolyzed whey) and Lacprodan® HYDRO.

What is Lacprodan used for?

Lacprodan is researched primarily for Muscle & Recovery and Athletic Performance. Whey protein supplies a leucine rich, quickly absorbed mix of essential amino acids that supports muscle protein synthesis. A pooled analysis of 49 resistance training trials in 1,863 adults found that adding protein gave about 2.

What is the recommended dosage of Lacprodan?

The clinically studied dose is No study has tested ALPHA-50, DI-3092 or HYDRO.365, so they have no studied dose. The cited whey studies used 20 to 45 g per serving. Lacprodan PL-20 was tested at 10 g twice daily for 4 weeks in healthy adults. Always follow the product label and check with a healthcare provider for personal advice.

Is Lacprodan safe, and does it have side effects?

For most healthy adults, Lacprodan is well tolerated at studied doses. Reported effects can include: Generally well tolerated in healthy adults at typical whey protein doses. Mild gastrointestinal discomfort, gas, or bloating possible. It may also interact with some medications. Lacprodan is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Lacprodan interact with any medications?

Possible interactions include: Levodopa: high protein meals can reduce levodopa absorption, so people with Parkinson's disease should follow their prescriber's advice on protein timing. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Lacprodan?

NutraSmarts rates the evidence for Lacprodan as Limited (2 out of 5). It is backed by 4 clinical trials and 14 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(14 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Power O, Hallihan A, Jakeman P. Human insulinotropic response to oral ingestion of native and hydrolysed whey protein. Amino Acids. 2009;37(2):333-9. doi: 10.1007/s00726-008-0156-0.PubMedUsed to support: Sixteen healthy men drank 500 mL containing 45 g of either whey protein isolate or whey protein hydrolysate; peak plasma insulin was 28 percent higher after the hydrolysate, although the 43 percent difference in total insulin exposure over time was not statistically significant and gastric emptying did not differ. A single acute study that measured no muscle, recovery or performance outcome and used generic whey rather than any Lacprodan ingredient.
  2. Bohé J, Low A, Wolfe RR, Rennie MJ. Human muscle protein synthesis is modulated by extracellular, not intramuscular amino acid availability: a dose-response study. J Physiol. 2003;552(Pt 1):315-24. doi: 10.1113/jphysiol.2003.050674.PubMedUsed to support: In 21 healthy adults given mixed amino acids by intravenous infusion, muscle protein synthesis tracked the concentration of amino acids in the blood rather than inside the muscle, rising along a curve that flattened out at high concentrations. The amino acids were infused into a vein rather than swallowed, so the study bypasses digestion and cannot describe what an oral protein powder does, and it involved no whey, no hydrolysate and no Lacprodan ingredient.
  3. van Vliet S, Burd NA, van Loon LJ. The Skeletal Muscle Anabolic Response to Plant- versus Animal-Based Protein Consumption. J Nutr. 2015;145(9):1981-91. doi: 10.3945/jn.114.204305.PubMedUsed to support: Narrative review concluding that soy and wheat protein produce a smaller muscle protein synthesis response per gram than animal proteins, partly because they contain less leucine and are less completely digested. The authors noted that few studies had measured the muscle response to plant proteins. It tested neither hydrolysis nor any Lacprodan ingredient, so at most it favours dairy protein over soy or wheat, not this brand over other whey.
  4. Morton RW, Murphy KT, McKellar SR, Schoenfeld BJ, Henselmans M, Helms E, Aragon AA, Devries MC, Banfield L, Krieger JW, Phillips SM. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med. 2018;52(6):376-384. doi: 10.1136/bjsports-2017-097608.PubMedUsed to support: Pooled analysis of 49 resistance-training trials in 1,863 healthy adults found that adding a protein supplement produced about 2.5 kg more on a one-repetition-maximum strength test and 0.3 kg more fat-free mass than training alone, with no further gain in fat-free mass above about 1.6 g of protein per kg of body weight per day. It covers protein supplementation in general, includes no Lacprodan ingredient, and does not show that a hydrolyzed or branded whey works better than ordinary protein.
  5. Kontro H, Kozior M, Whelehan G, Amigo-Benavent M, Norton C, Carson BP, Jakeman P. Carbohydrate and Protein Co-Ingestion Postexercise Does Not Improve Next-Day Performance in Trained Cyclists. Int J Sport Nutr Exerc Metab. 2021;31(6):466-474. doi: 10.1123/ijsnem.2021-0069.PubMedUsed to support: Double-blind crossover study in 12 trained men who, after glycogen-depleting exercise, drank carbohydrate alone, carbohydrate plus whey protein concentrate, or carbohydrate plus whey protein hydrolysate. Next-day 30-minute time-trial performance was the same in all three trials (p = 0.83), although the protein drinks produced a higher insulin response; total 24-hour food and calorie intake was controlled. A small, all-male study, and the hydrolysate was not a Lacprodan ingredient.
  6. Buckley JD, Thomson RL, Coates AM, Howe PR, DeNichilo MO, Rowney MK. Supplementation with a whey protein hydrolysate enhances recovery of muscle force-generating capacity following eccentric exercise. J Sci Med Sport. 2010;13(1):178-81. doi: 10.1016/j.jsams.2008.06.007.PubMedUsed to support: In a double-blind parallel trial in 28 sedentary men who performed 100 maximal eccentric knee contractions, 25 g of a whey protein isolate hydrolysate restored peak isometric torque by 6 hours while flavoured water and intact whey protein isolate did not; soreness, creatine kinase and TNF-alpha did not differ between groups. Only six men received the hydrolysate, the participants were not athletes, and the product was not a Lacprodan ingredient.
  7. Oikawa SY, Macinnis MJ, Tripp TR, McGlory C, Baker SK, Phillips SM. Lactalbumin, Not Collagen, Augments Muscle Protein Synthesis with Aerobic Exercise. Med Sci Sports Exerc. 2020;52(6):1394-1403. doi: 10.1249/MSS.0000000000002253.PubMedUsed to support: Double-blind crossover trial in 11 endurance-trained adults taking 20 g of alpha-lactalbumin after exercise and 40 g before sleep across three days of intensified training; myofibrillar protein synthesis was about 13 percent higher than with collagen peptides, alongside higher blood leucine and tryptophan. The comparator was collagen, a lower-quality protein, rather than placebo or standard whey; the sample was small; the outcome was a synthesis rate rather than strength or performance; and the alpha-lactalbumin was not a Lacprodan product.
  8. Dybdahl M, Selesko DB, Mikkelsen UR. Safety evaluation of whey derived beta-lactoglobulin, Lacprodan® BLG. Toxicol Rep. 2021;8:617-626. doi: 10.1016/j.toxrep.2021.03.012.PubMedUsed to support: Safety package on Lacprodan BLG, a whey-derived beta-lactoglobulin, reporting no mutagenic activity in a bacterial reverse mutation assay, no chromosome damage in a micronucleus test in human white blood cells, and no treatment-related effects in a 90-day study in rats dosed by mouth (gavage) at up to 1,000 mg per kg of body weight per day. Written by Arla Foods Ingredients employees with a consultancy the company paid; it covers safety only, in rats and cell assays rather than people, and a different grade from the sports hydrolysates.
  9. Ten Bruggencate SJ, Frederiksen PD, Pedersen SM, Floris-Vollenbroek EG, Lucas-van de Bos E, van Hoffen E, Wejse PL. Dietary Milk-Fat-Globule Membrane Affects Resistance to Diarrheagenic Escherichia coli in Healthy Adults in a Randomized, Placebo-Controlled, Double-Blind Study. J Nutr. 2016;146(2):249-55. doi: 10.3945/jn.115.214098.PubMedUsed to support: Randomized, double blind, 4 week trial in 58 healthy adults comparing 10 g of Lacprodan PL-20, a milk protein concentrate rich in milk fat globule membrane, twice daily with sodium caseinate before an oral challenge with a weakened diarrhoea causing E. coli strain. Fecal wet weight and E. coli excretion did not differ; reported stool frequency and gut complaints were lower with PL-20. Arla staff were co-authors.
  10. Schubert M, Contreras C, Franz N, Hellhammer J. Milk-based phospholipids increase morning cortisol availability and improve memory in chronically stressed men. Nutr Res. 2011;31(6):413-20. doi: 10.1016/j.nutres.2011.05.012.PubMedUsed to support: Placebo controlled trial in 75 chronically stressed men aged 30 to 51 given a milk drink with 0.5% or 1% added milk phospholipids for 42 days. Both doses delayed the morning decline in salivary cortisol, the acute stress response did not differ from placebo, and better memory after a stress test was seen only in an exploratory analysis of older men on the higher dose. The abstract does not name the ingredient; a 2026 review lists it as Lacprodan PL-20.
  11. Borkar AS, Todorova Y, Markey O. Impact of Milk Fat Globule Membrane and Its Associated Polar Lipids on Markers of Cardiometabolic Disease and Cognitive Function: A Systematic Review and Meta-Analysis of Randomized Controlled Trials in Adults. Adv Nutr. 2026;17(9):100694. doi: 10.1016/j.advnut.2026.100694.PubMedUsed to support: Systematic review of milk fat globule membrane trials in adults. Its study table identifies the milk phospholipid ingredient in Schubert 2011 as Lacprodan PL-20 supplied by Arla Foods Ingredients, and lists PL-20 in a buttermilk drink in another adult trial. Used here only to identify which Lacprodan grade was tested.
  12. Scholey AB, Camfield DA, Hughes ME, Woods W, K Stough CK, White DJ, Gondalia SV, Frederiksen PD. A randomized controlled trial investigating the neurocognitive effects of Lacprodan® PL-20, a phospholipid-rich milk protein concentrate, in elderly participants with age-associated memory impairment: the Phospholipid Intervention for Cognitive Ageing Reversal (PLICAR): study protocol for a randomized controlled trial. Trials. 2013;14:404. doi: 10.1186/1745-6215-14-404.PubMedUsed to support: Protocol for a planned 6 month, double blind trial of Lacprodan PL-20 in 150 adults over 55 with age associated memory impairment, jointly funded by Arla Foods and Swinburne University. It is a study plan, not results.
  13. Zajac IT, Kakoschke N, Evas S, Kuhn-Sherlock B, Wood K, King R, Arnoldy L, Dekker J, Gunn C, Fuad M, Scholey A, MacGibbon A, White DJ. The effect of milk fat globule membrane phospholipid supplementation on cognitive function in older adults with subjective memory complaints-a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2025;122(5):1161-1173. doi: 10.1016/j.ajcnut.2025.09.005.PubMedUsed to support: A 16 week trial of a different milk fat globule membrane product (not Lacprodan) in 263 adults aged 55 to 75, which found no effect on its primary cognitive outcome. Its introduction states that results of the Lacprodan PL-20 memory trial are unreported. Cited here only for that statement.
  14. Arla Foods Ingredients. New medical nutrition ingredient combines high-protein with best taste yet. Arla Foods Ingredients press release. 2024;Press release, 5 November 2024..SourceUsed to support: Not PubMed-indexed (manufacturer press release). Describes Lacprodan DI-3092 as a highly hydrolysed whey protein (16 to 22 percent degree of hydrolysis) with mild taste, low viscosity and low lactose, allowing 10 g of protein per 100 mL in peptide-based medical nutrition drinks. Makes no clinical outcome claim.